Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease

被引：47

作者：

Egan, Jan B. ^{[1
]}

Kortuem, K. Martin ^{[1
]}

Kurdoglu, Ahmet ^{[2
]}

Izatt, Tyler ^{[2
]}

Aldrich, Jessica ^{[2
]}

Reiman, Rebecca ^{[2
]}

Phillips, Lori ^{[2
]}

Baker, Angela ^{[2
]}

Shi, Chang-Xin ^{[1
]}

Schmidt, Jessica ^{[1
]}

Liang, Winnie S. ^{[2
]}

Craig, David W. ^{[2
]}

Carpten, John D. ^{[2
]}

Stewart, A. Keith ^{[1
]}

机构：

[1] Mayo Clin Scottsdale, Scottsdale, AZ 85259 USA

[2] Translat Genom Res Inst, Phoenix, AZ USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 161卷 / 05期

关键词：

myeloma; CRBN; NR3C1; PSMG2; drug resistance; EXPRESSION;

D O I：

10.1111/bjh.12291

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：748 / 751

页数：4

共 10 条

[1] Targeting the PI3K signaling pathway in cancer therapy [J].

Bartholomeusz, Chandra ;

Gonzalez-Angulo, Ana Maria .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) :121-130

[2] Variations of the human glucocorticoid receptor gene (NR3C1): Pathological and in vitro mutations.and polymorphisms [J].

Bray, PJ ;

Cotton, RGH .

HUMAN MUTATION, 2003, 21 (06) :557-568

[3] Initial genome sequencing and analysis of multiple myeloma [J].

Chapman, Michael A. ;

Lawrence, Michael S. ;

Keats, Jonathan J. ;

Cibulskis, Kristian ;

Sougnez, Carrie ;

Schinzel, Anna C. ;

Harview, Christina L. ;

Brunet, Jean-Philippe ;

Ahmann, Gregory J. ;

Adli, Mazhar ;

Anderson, Kenneth C. ;

Ardlie, Kristin G. ;

Auclair, Daniel ;

Baker, Angela ;

Bergsagel, P. Leif ;

Bernstein, Bradley E. ;

Drier, Yotam ;

Fonseca, Rafael ;

Gabriel, Stacey B. ;

Hofmeister, Craig C. ;

Jagannath, Sundar ;

Jakubowiak, Andrzej J. ;

Krishnan, Amrita ;

Levy, Joan ;

Liefeld, Ted ;

Lonial, Sagar ;

Mahan, Scott ;

Mfuko, Bunmi ;

Monti, Stefano ;

Perkins, Louise M. ;

Onofrio, Robb ;

Pugh, Trevor J. ;

Rajkumar, S. Vincent ;

Ramos, Alex H. ;

Siegel, David S. ;

Sivachenko, Andrey ;

Stewart, A. Keith ;

Trudel, Suzanne ;

Vij, Ravi ;

Voet, Douglas ;

Winckler, Wendy ;

Zimmerman, Todd ;

Carpten, John ;

Trent, Jeff ;

Hahn, William C. ;

Garraway, Levi A. ;

Meyerson, Matthew ;

Lander, Eric S. ;

Getz, Gad ;

Golub, Todd R. .

NATURE, 2011, 471 (7339) :467-472

[4] Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1 [J].

Heuck, Christoph J. ;

Szymonifka, Jackie ;

Hansen, Emily ;

Shaughnessy, John D., Jr. ;

Usmani, Saad Z. ;

van Rhee, Frits ;

Anaissie, Elias ;

Nair, Bijay ;

Waheed, Sarah ;

Alsayed, Yazan ;

Petty, Nathan ;

Bailey, Clyde ;

Epstein, Joshua ;

Hoering, Antje ;

Crowley, John ;

Barlogie, Bart .

CLINICAL CANCER RESEARCH, 2012, 18 (19) :5499-5506

[5] A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes [J].

Hirano, Y ;

Hendil, KB ;

Yashiroda, H ;

Iemura, S ;

Nagane, R ;

Hioki, Y ;

Natsume, T ;

Tanaka, K ;

Murata, S .

NATURE, 2005, 437 (7063) :1381-1385

[6] PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials [J].

Janku, Filip ;

Wheler, Jennifer J. ;

Naing, Aung ;

Falchook, Gerald S. ;

Hong, David S. ;

Stepanek, Vanda M. ;

Fu, Siqing ;

Piha-Paul, Sarina A. ;

Lee, J. Jack ;

Luthra, Rajyalakshmi ;

Tsimberidou, Apostolia M. ;

Kurzrock, Razelle .

CANCER RESEARCH, 2013, 73 (01) :276-284

[7] Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma [J].

Keats, Jonathan J. ;

Fonseca, Rafael ;

Chesi, Marta ;

Schop, Roelandt ;

Baker, Angela ;

Ching, Wee-Joo ;

Van Wier, Scott ;

Tiedemann, Rodger ;

Shi, Chang-Xin ;

Sebag, Michael ;

Braggio, Esteban ;

Henry, Travis ;

Zhu, Yuan-Xiao ;

Fogle, Homer ;

Price-Troska, Tammy ;

Ahmann, Gregory ;

Mancini, Catherine ;

Brents, Leslie A. ;

Kumar, Shaji ;

Greipp, Philip ;

Dispenzieri, Angela ;

Bryant, Barb ;

Mulligan, George ;

Bruhn, Laurakay ;

Barrett, Michael ;

Valdez, Riccardo ;

Trent, Jeff ;

Stewart, A. Keith ;

Carpten, John ;

Bergsagel, P. Leif .

CANCER CELL, 2007, 12 (02) :131-144

[8]

MOALLI PA, 1992, BLOOD, V79, P213

[9] Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma [J].

Walker, Brian A. ;

Wardell, Christopher P. ;

Melchor, Lorenzo ;

Hulkki, Sanna ;

Potter, Nicola E. ;

Johnson, David C. ;

Fenwick, Kerry ;

Kozarewa, Iwanka ;

Gonzalez, David ;

Lord, Christopher J. ;

Ashworth, Alan ;

Davies, Faith E. ;

Morgan, Gareth J. .

BLOOD, 2012, 120 (05) :1077-1086

[10] Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide [J].

Zhu, Yuan Xiao ;

Braggio, Esteban ;

Shi, Chang-Xin ;

Bruins, Laura A. ;

Schmidt, Jessica E. ;

Van Wier, Scott ;

Chang, Xiu-Bao ;

Bjorklund, Chad C. ;

Fonseca, Rafael ;

Bergsagel, P. Leif ;

Orlowski, Robert Z. ;

Stewart, A. Keith .

BLOOD, 2011, 118 (18) :4771-4779

← 1 →